Dr William Pollock Warfield, MD | |
1000 Jerry St. Pe' Hyw., Pascagoula, MS 39568-0149 | |
(228) 935-1383 | |
(228) 933-7370 |
Full Name | Dr William Pollock Warfield |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 1000 Jerry St. Pe' Hyw., Pascagoula, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033234265 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 05688 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William Pollock Warfield, MD 1017 Eastwood St, Pascagoula, MS 39567-7555 Ph: (228) 762-2446 | Dr William Pollock Warfield, MD 1000 Jerry St. Pe' Hyw., Pascagoula, MS 39568-0149 Ph: (228) 935-1383 |
News Archive
Radiometer has unveiled its CE-marked TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric and adult patients, as well as sleep clinic and home care environments.
IsilonĀ® Systems today announced that The Translational Genomics Research Institute has deployed Isilon scale-out NAS as the primary storage solution powering its next-generation biomedical research. By using Isilon IQ to power multiple genome sequencing devices, TGen has unified its mission-critical operations onto a single, high-performance, highly scalable shared pool of storage, increasing workflow productivity and reducing costs to accelerate the discovery of new treatments for life-threatening diseases.
Scientists have successfully completed an initial trial of a new, potentially more reliable, technique for screening breast cancer using ultrasound. The team at the National Physical Laboratory (NPL), the UK's National Measurement Institute, working with the University Hospitals Bristol NHS Foundation Trust, are now looking to develop the technique into a clinical device.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
With efforts to pass a national health care bill at a stalemate in Washington, two newspaper explore some of the options. The New York Times reports: "As Republicans and Democrats claim to be searching for common ground in the health care debate, one idea that lawmakers on both sides seem to agree on is that health insurance should be sold across state lines.
› Verified 1 days ago
Dr. John Thomas Pessoney, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5912 Old Mobile Highway, Suite 1, Pascagoula, MS 39581 Phone: 228-471-1000 Fax: 228-471-1039 |